miR‐181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF 1 expression-Reference-Cited by-同舟云学术

miR‐181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF 1 expression

Published:2016-09 Issue:9 Volume:107 Page:1256-1262
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Azumi Junya¹,Tsubota Toshiaki¹,Sakabe Tomohiko¹,Shiota Goshi¹

Affiliation:

1. Division of Molecular and Genetic Medicine Department of Genetic Medicine and Regenerative Therapeutics Graduate School of Medicine Tottori University Yonago Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13006

Reference32 articles.

1. Cancer statistics, 2011

2. Management of HCC

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

5. Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of the MiR-181 Family in Hepatocellular Carcinoma;Cells;2024-07-31

2. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis;Frontiers in Immunology;2024-05-10

3. The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance;Technology in Cancer Research & Treatment;2024-01

4. Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow;Biomedicine & Pharmacotherapy;2023-11

5. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications;Cancers;2023-10-27